logo dark logo light logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
logo dark logo light logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
mobile-logo
  • Solutions
    • Modelling and Simulation
      • Mechanism of Action Modelling
      • Exposure Response Modelling
      • Translational Modelling
      • Tumour Growth Inhibition Modelling
      • Population PK and NCA
      • PBPK Modelling
      • Clinical Trial Simulation
    • Biostatistics
    • Data Science & Bioinformatics
  • Virtual Tumour
  • Precision Oncology
  • Resources
    • Scientific Content
    • Investor Content
    • FAQs
  • News
    • All News
    • Investor News / RNS
    • Blog
    • Events
  • AIM Rule 26
    • Share Information
    • Investor News / RNS
    • Board of Directors
    • Advisors
    • Corporate Governance
    • Financial Reports
    • Corporate Documents
    • Registration
  • About Us
    • Partners
    • Team
    • Careers
  • Contact
 

Corporate Documents

Notice of General Meeting

  • Notice of Annual General Meeting 19th November 2024
  • Notice of Annual General Meeting 21st November 2023
  • Notice of Annual General Meeting 22nd November 2022
  • Notice of Annual General Meeting 23rd November 2021
  • Notice of Annual General Meeting 17th November 2020
  • Notice of Annual General Meeting 19th November 2019
  • Notice of Annual General Meeting 20th November 2018
  • Notice of Annual General Meeting 13th December 2017
  • Notice of Annual General Meeting 16th December 2016
  • Notice of General Meeting of 7 September 2016
  • Notice of General Meeting of 14 December 2015

Constitutional documents

  • Articles of Association
  • Admission document
  • Share Information
  • Investor News / RNS
  • Board of Directors
  • Advisors
  • Corporate Governance
    • Key QCA Principles
    • 2024 AGM Voting
  • Financial Reports
  • Corporate Documents
  • Registration
logo

Physiomics Plc

Bee House

140 Eastern Avenue

Milton Park

Oxfordshire, OX14 4SB

United Kingdom

Email: info@physiomics.co.uk

Phone: +44 (0) 1235 841575

Quick Links

  • About
  • R&D Services
  • Resources
  • All News
  • Blog
  • AIM Rule 26
  • Legal & Privacy Policy
  • Sitemap
  • Contact
Newsletter
Receive news and updates from Physiomics. Select your interest below:
Corporate
Scientific

Copyright © Physiomics Plc 2025. Physiomics® is a registered trademark of Physiomics Plc.